Standard Biotools (LAB) Revenue Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 127.04 Bn | 123.56 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.03 Bn | 22.54 Bn | 684.20 Mn | 7.30% |
| 10 | Standard Biotools | 251.92 Mn | -224.80 Mn | 10.54 Mn | -7.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.62% |
| Mar 31, 2026 | 4.57% |
| Dec 31, 2025 | -3.96% |
| Sep 30, 2025 | -11.47% |
| Jun 30, 2025 | -3.25% |
| Mar 31, 2025 | -55.60% |
| Dec 31, 2024 | -12.10% |
| Sep 30, 2024 | -12.93% |
| Jun 30, 2024 | -18.70% |
| Mar 31, 2024 | 81.30% |
| Dec 31, 2023 | 4.32% |
| Sep 30, 2023 | -1.09% |
| Jun 30, 2023 | 47.34% |
| Mar 31, 2023 | -5.23% |
| Sep 30, 2022 | -72.22% |
| Jun 30, 2022 | -70.57% |
| Mar 31, 2022 | -19.18% |
| Sep 30, 2021 | 131.59% |
| Jun 30, 2021 | 144.88% |
| Mar 31, 2021 | 18.75% |